Skip to main content
. 2019;20(11):3465–3472. doi: 10.31557/APJCP.2019.20.11.3465

Figure 2.

Figure 2

ROC Curve Analysis Assessing the Performance of sHLA-G in Discriminating between A, metastatic and non-metastatic breast cancer patients; B, mastectomized and non-mastectomized breast cancer patients